ICD↔CPT crosswalk
CPT 95044: ICD-10 codes that support medical necessity
These ICD-10-CM diagnoses support medical necessity for CPT 95044 under Medicare coverage policies (LCDs, NCDs, and Billing & Coding articles). Billing CPT 95044 with a diagnosis that isn't covered typically denies as CARC 50 — not medically necessary.
National approximation. Coverage varies by MAC and state — confirm against the specific LCD/NCD and article that applies to your jurisdiction and date of service.
| ICD-10 | Description |
|---|---|
| B44.0 | Invasive pulmonary aspergillosis |
| B44.81 | Allergic bronchopulmonary aspergillosis |
| E80.0 | Hereditary erythropoietic porphyria |
| E80.1 | Porphyria cutanea tarda |
| E80.21 | Acute intermittent (hepatic) porphyria |
| E80.29 | Other porphyria |
| H01.111 | Allergic dermatitis of right upper eyelid |
| H01.112 | Allergic dermatitis of right lower eyelid |
| H01.114 | Allergic dermatitis of left upper eyelid |
| H01.115 | Allergic dermatitis of left lower eyelid |
| H01.131 | Eczematous dermatitis of right upper eyelid |
| H01.132 | Eczematous dermatitis of right lower eyelid |
| H01.134 | Eczematous dermatitis of left upper eyelid |
| H01.135 | Eczematous dermatitis of left lower eyelid |
| H10.11 | Acute atopic conjunctivitis, right eye |
| H10.12 | Acute atopic conjunctivitis, left eye |
| H10.13 | Acute atopic conjunctivitis, bilateral |
| H10.31 | Unspecified acute conjunctivitis, right eye |
| H10.32 | Unspecified acute conjunctivitis, left eye |
| H10.33 | Unspecified acute conjunctivitis, bilateral |
| H10.411 | Chronic giant papillary conjunctivitis, right eye |
| H10.412 | Chronic giant papillary conjunctivitis, left eye |
| H10.413 | Chronic giant papillary conjunctivitis, bilateral |
| H10.44 | Vernal conjunctivitis |
| H10.45 | Other chronic allergic conjunctivitis |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H65.01 | Acute serous otitis media, right ear |
| H65.02 | Acute serous otitis media, left ear |
| H65.03 | Acute serous otitis media, bilateral |
| H65.04 | Acute serous otitis media, recurrent, right ear |
| H65.05 | Acute serous otitis media, recurrent, left ear |
| H65.06 | Acute serous otitis media, recurrent, bilateral |
| H65.111 | Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), right ear |
| H65.112 | Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), left ear |
| H65.113 | Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), bilateral |
| H65.114 | Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), recurrent, right ear |
| H65.115 | Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), recurrent, left ear |
| H65.116 | Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), recurrent, bilateral |
| H65.194 | Other acute nonsuppurative otitis media, recurrent, right ear |
| H65.195 | Other acute nonsuppurative otitis media, recurrent, left ear |
| H65.196 | Other acute nonsuppurative otitis media, recurrent, bilateral |
| H65.21 | Chronic serous otitis media, right ear |
| H65.22 | Chronic serous otitis media, left ear |
| H65.23 | Chronic serous otitis media, bilateral |
| H65.411 | Chronic allergic otitis media, right ear |
| H65.412 | Chronic allergic otitis media, left ear |
| H65.413 | Chronic allergic otitis media, bilateral |
| H65.491 | Other chronic nonsuppurative otitis media, right ear |
| H65.492 | Other chronic nonsuppurative otitis media, left ear |
| H65.493 | Other chronic nonsuppurative otitis media, bilateral |
| H66.91 | Otitis media, unspecified, right ear |
| H66.92 | Otitis media, unspecified, left ear |
| H66.93 | Otitis media, unspecified, bilateral |
| H68.011 | Acute Eustachian salpingitis, right ear |
| H68.012 | Acute Eustachian salpingitis, left ear |
| H68.013 | Acute Eustachian salpingitis, bilateral |
| H68.021 | Chronic Eustachian salpingitis, right ear |
| H68.022 | Chronic Eustachian salpingitis, left ear |
| H68.023 | Chronic Eustachian salpingitis, bilateral |
| H69.81 | Other specified disorders of Eustachian tube, right ear |
| H69.82 | Other specified disorders of Eustachian tube, left ear |
| H69.83 | Other specified disorders of Eustachian tube, bilateral |
| J01.00 | Acute maxillary sinusitis, unspecified |
| J01.01 | Acute recurrent maxillary sinusitis |
| J01.10 | Acute frontal sinusitis, unspecified |
| J01.11 | Acute recurrent frontal sinusitis |
| J01.20 | Acute ethmoidal sinusitis, unspecified |
| J01.21 | Acute recurrent ethmoidal sinusitis |
| J01.30 | Acute sphenoidal sinusitis, unspecified |
| J01.31 | Acute recurrent sphenoidal sinusitis |
| J01.40 | Acute pansinusitis, unspecified |
| J01.41 | Acute recurrent pansinusitis |
| J01.80 | Other acute sinusitis |
| J01.81 | Other acute recurrent sinusitis |
| J01.90 | Acute sinusitis, unspecified |
| J01.91 | Acute recurrent sinusitis, unspecified |
| J04.0 | Acute laryngitis |
| J04.30 | Supraglottitis, unspecified, without obstruction |
| J04.31 | Supraglottitis, unspecified, with obstruction |
| J05.0 | Acute obstructive laryngitis [croup] |
| J20.8 | Acute bronchitis due to other specified organisms |
| J30.0 | Vasomotor rhinitis |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| J30.5 | Allergic rhinitis due to food |
| J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
| J30.89 | Other allergic rhinitis |
| J30.9 | Allergic rhinitis, unspecified |
| J31.0 | Chronic rhinitis |
| J31.1 | Chronic nasopharyngitis |
| J31.2 | Chronic pharyngitis |
| J32.0 | Chronic maxillary sinusitis |
| J32.1 | Chronic frontal sinusitis |
| J32.2 | Chronic ethmoidal sinusitis |
| J32.3 | Chronic sphenoidal sinusitis |
| J32.4 | Chronic pansinusitis |
| J32.8 | Other chronic sinusitis |
| J32.9 | Chronic sinusitis, unspecified |
| J33.0 | Polyp of nasal cavity |
| J33.1 | Polypoid sinus degeneration |
| J33.8 | Other polyp of sinus |
| J33.9 | Nasal polyp, unspecified |
| J34.1 | Cyst and mucocele of nose and nasal sinus |
| J34.3 | Hypertrophy of nasal turbinates |
| J34.81 | Nasal mucositis (ulcerative) |
| J34.8200 | Internal nasal valve collapse, unspecified |
| J34.8201 | Internal nasal valve collapse, static |
| J34.8202 | Internal nasal valve collapse, dynamic |
| J34.8210 | External nasal valve collapse, unspecified |
| J34.8211 | External nasal valve collapse, static |
| J34.8212 | External nasal valve collapse, dynamic |
| J34.829 | Nasal valve collapse, unspecified |
| J34.89 | Other specified disorders of nose and nasal sinuses |
| J35.01 | Chronic tonsillitis |
| J35.02 | Chronic adenoiditis |
| J35.03 | Chronic tonsillitis and adenoiditis |
| J35.1 | Hypertrophy of tonsils |
| J35.2 | Hypertrophy of adenoids |
| J35.3 | Hypertrophy of tonsils with hypertrophy of adenoids |
| J44.1 | Chronic obstructive pulmonary disease with (acute) exacerbation |
| J44.89 | Other specified chronic obstructive pulmonary disease |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.21 | Mild intermittent asthma with (acute) exacerbation |
| J45.22 | Mild intermittent asthma with status asthmaticus |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.31 | Mild persistent asthma with (acute) exacerbation |
| J45.32 | Mild persistent asthma with status asthmaticus |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.41 | Moderate persistent asthma with (acute) exacerbation |
| J45.42 | Moderate persistent asthma with status asthmaticus |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.51 | Severe persistent asthma with (acute) exacerbation |
| J45.52 | Severe persistent asthma with status asthmaticus |
| J45.901 | Unspecified asthma with (acute) exacerbation |
| J45.902 | Unspecified asthma with status asthmaticus |
| J45.909 | Unspecified asthma, uncomplicated |
| J45.990 | Exercise induced bronchospasm |
| J45.991 | Cough variant asthma |
| J45.998 | Other asthma |
| J47.9 | Bronchiectasis, uncomplicated |
| K20.0 | Eosinophilic esophagitis |
| K29.30 | Chronic superficial gastritis without bleeding |
| K29.60 | Other gastritis without bleeding |
| K52.21 | Food protein-induced enterocolitis syndrome |
| K52.22 | Food protein-induced enteropathy |
| K52.29 | Other allergic and dietetic gastroenteritis and colitis |
| K52.3 | Indeterminate colitis |
| K52.831 | Collagenous colitis |
| K52.832 | Lymphocytic colitis |
| K52.838 | Other microscopic colitis |
| K52.89 | Other specified noninfective gastroenteritis and colitis |
| L20.0 | Besnier's prurigo |
| L20.81 | Atopic neurodermatitis |
| L20.82 | Flexural eczema |
| L20.83 | Infantile (acute) (chronic) eczema |
| L20.84 | Intrinsic (allergic) eczema |
| L20.89 | Other atopic dermatitis |
| L20.9 | Atopic dermatitis, unspecified |
| L23.0 | Allergic contact dermatitis due to metals |
| L23.1 | Allergic contact dermatitis due to adhesives |
| L23.2 | Allergic contact dermatitis due to cosmetics |
| L23.3 | Allergic contact dermatitis due to drugs in contact with skin |
| L23.4 | Allergic contact dermatitis due to dyes |
| L23.5 | Allergic contact dermatitis due to other chemical products |
| L23.6 | Allergic contact dermatitis due to food in contact with the skin |
| L23.7 | Allergic contact dermatitis due to plants, except food |
| L23.81 | Allergic contact dermatitis due to animal (cat) (dog) dander |
| L23.89 | Allergic contact dermatitis due to other agents |
| L23.9 | Allergic contact dermatitis, unspecified cause |
| L24.0 | Irritant contact dermatitis due to detergents |
| L24.1 | Irritant contact dermatitis due to oils and greases |
| L24.2 | Irritant contact dermatitis due to solvents |
| L24.3 | Irritant contact dermatitis due to cosmetics |
| L24.4 | Irritant contact dermatitis due to drugs in contact with skin |
| L24.5 | Irritant contact dermatitis due to other chemical products |
| L24.6 | Irritant contact dermatitis due to food in contact with skin |
| L24.7 | Irritant contact dermatitis due to plants, except food |
| L24.81 | Irritant contact dermatitis due to metals |
| L24.89 | Irritant contact dermatitis due to other agents |
| L24.9 | Irritant contact dermatitis, unspecified cause |
| L25.0 | Unspecified contact dermatitis due to cosmetics |
| L25.1 | Unspecified contact dermatitis due to drugs in contact with skin |
| L25.2 | Unspecified contact dermatitis due to dyes |
| L25.3 | Unspecified contact dermatitis due to other chemical products |
| L25.4 | Unspecified contact dermatitis due to food in contact with skin |
| L25.5 | Unspecified contact dermatitis due to plants, except food |
| L25.8 | Unspecified contact dermatitis due to other agents |
| L25.9 | Unspecified contact dermatitis, unspecified cause |
| L26 | Exfoliative dermatitis |
| L27.0 | Generalized skin eruption due to drugs and medicaments taken internally |
| L27.1 | Localized skin eruption due to drugs and medicaments taken internally |
| L27.2 | Dermatitis due to ingested food |
| L27.8 | Dermatitis due to other substances taken internally |
| L27.9 | Dermatitis due to unspecified substance taken internally |
| L28.0 | Lichen simplex chronicus |
| L29.89 | Other pruritus |
| L29.9 | Pruritus, unspecified |
| L30.0 | Nummular dermatitis |
| L30.1 | Dyshidrosis [pompholyx] |
| L30.2 | Cutaneous autosensitization |
| L30.4 | Erythema intertrigo |
| L30.8 | Other specified dermatitis |
| L30.9 | Dermatitis, unspecified |
| L50.0 | Allergic urticaria |
| L50.1 | Idiopathic urticaria |
| L50.3 | Dermatographic urticaria |
| L50.6 | Contact urticaria |
| L50.8 | Other urticaria |
| L50.9 | Urticaria, unspecified |
| L53.8 | Other specified erythematous conditions |
| L54 | Erythema in diseases classified elsewhere |
| L56.0 | Drug phototoxic response |
| L56.1 | Drug photoallergic response |
| L56.2 | Photocontact dermatitis [berloque dermatitis] |
| L56.3 | Solar urticaria |
| L56.4 | Polymorphous light eruption |
| L56.8 | Other specified acute skin changes due to ultraviolet radiation |
| L57.1 | Actinic reticuloid |
| L57.5 | Actinic granuloma |
| L57.8 | Other skin changes due to chronic exposure to nonionizing radiation |
| L58.0 | Acute radiodermatitis |
| L58.1 | Chronic radiodermatitis |
| L59.0 | Erythema ab igne [dermatitis ab igne] |
| L59.8 | Other specified disorders of the skin and subcutaneous tissue related to radiation |
| L92.0 | Granuloma annulare |
| L92.2 | Granuloma faciale [eosinophilic granuloma of skin] |
| L95.1 | Erythema elevatum diutinum |
| L98.2 | Febrile neutrophilic dermatosis [Sweet] |
| R05.1 | Acute cough |
| R05.2 | Subacute cough |
| R05.3 | Chronic cough |
| R05.4 | Cough syncope |
| R05.8 | Other specified cough |
| R05.9 | Cough, unspecified |
| R06.00 | Dyspnea, unspecified |
| R06.02 | Shortness of breath |
| R06.03 | Acute respiratory distress |
| R06.09 | Other forms of dyspnea |
| R06.2 | Wheezing |
| R06.83 | Snoring |
| R06.89 | Other abnormalities of breathing |
| R06.9 | Unspecified abnormalities of breathing |
| R09.81 | Nasal congestion |
| R11.0 | Nausea |
| R11.10 | Vomiting, unspecified |
| R11.11 | Vomiting without nausea |
| R11.12 | Projectile vomiting |
| R11.2 | Nausea with vomiting, unspecified |
| R14.0 | Abdominal distension (gaseous) |
| R14.1 | Gas pain |
| R14.2 | Eructation |
| R14.3 | Flatulence |
| R19.7 | Diarrhea, unspecified |
| R21 | Rash and other nonspecific skin eruption |
| R23.8 | Other skin changes |
| R23.9 | Unspecified skin changes |
| R43.0 | Anosmia |
| R43.1 | Parosmia |
| R43.2 | Parageusia |
| R43.8 | Other disturbances of smell and taste |
| R43.9 | Unspecified disturbances of smell and taste |
| T36.0X5A | Adverse effect of penicillins, initial encounter |
| T36.0X5D | Adverse effect of penicillins, subsequent encounter |
| T36.0X5S | Adverse effect of penicillins, sequela |
| T36.0X6A | Underdosing of penicillins, initial encounter |
| T36.0X6D | Underdosing of penicillins, subsequent encounter |
| T36.0X6S | Underdosing of penicillins, sequela |
| T36.1X1A | Poisoning by cephalosporins and other beta-lactam antibiotics, accidental (unintentional), initial encounter |
| T36.1X1D | Poisoning by cephalosporins and other beta-lactam antibiotics, accidental (unintentional), subsequent encounter |
| T36.1X1S | Poisoning by cephalosporins and other beta-lactam antibiotics, accidental (unintentional), sequela |
| T36.1X2A | Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, initial encounter |
| T36.1X2D | Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, subsequent encounter |
| T36.1X2S | Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, sequela |
| T36.1X3A | Poisoning by cephalosporins and other beta-lactam antibiotics, assault, initial encounter |
| T36.1X3D | Poisoning by cephalosporins and other beta-lactam antibiotics, assault, subsequent encounter |
| T36.1X3S | Poisoning by cephalosporins and other beta-lactam antibiotics, assault, sequela |
| T36.1X4A | Poisoning by cephalosporins and other beta-lactam antibiotics, undetermined, initial encounter |
| T36.1X4D | Poisoning by cephalosporins and other beta-lactam antibiotics, undetermined, subsequent encounter |
| T36.1X4S | Poisoning by cephalosporins and other beta-lactam antibiotics, undetermined, sequela |
| T36.1X5A | Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter |
| T36.1X5D | Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter |
| T36.1X5S | Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela |
| T36.1X6A | Underdosing of cephalosporins and other beta-lactam antibiotics, initial encounter |
| T36.1X6D | Underdosing of cephalosporins and other beta-lactam antibiotics, subsequent encounter |
| T36.1X6S | Underdosing of cephalosporins and other beta-lactam antibiotics, sequela |
| T36.2X1A | Poisoning by chloramphenicol group, accidental (unintentional), initial encounter |
| T36.2X1D | Poisoning by chloramphenicol group, accidental (unintentional), subsequent encounter |
| T36.2X1S | Poisoning by chloramphenicol group, accidental (unintentional), sequela |
| T36.2X2A | Poisoning by chloramphenicol group, intentional self-harm, initial encounter |
| T36.2X2D | Poisoning by chloramphenicol group, intentional self-harm, subsequent encounter |
| T36.2X2S | Poisoning by chloramphenicol group, intentional self-harm, sequela |
| T36.2X3A | Poisoning by chloramphenicol group, assault, initial encounter |
| T36.2X3D | Poisoning by chloramphenicol group, assault, subsequent encounter |
| T36.2X3S | Poisoning by chloramphenicol group, assault, sequela |
| T36.2X4A | Poisoning by chloramphenicol group, undetermined, initial encounter |
| T36.2X4D | Poisoning by chloramphenicol group, undetermined, subsequent encounter |
| T36.2X4S | Poisoning by chloramphenicol group, undetermined, sequela |
| T36.2X5A | Adverse effect of chloramphenicol group, initial encounter |
| T36.2X5D | Adverse effect of chloramphenicol group, subsequent encounter |
| T36.2X5S | Adverse effect of chloramphenicol group, sequela |
| T36.2X6A | Underdosing of chloramphenicol group, initial encounter |
| T36.2X6D | Underdosing of chloramphenicol group, subsequent encounter |
| T36.2X6S | Underdosing of chloramphenicol group, sequela |
| T36.3X1A | Poisoning by macrolides, accidental (unintentional), initial encounter |
| T36.3X1D | Poisoning by macrolides, accidental (unintentional), subsequent encounter |
| T36.3X1S | Poisoning by macrolides, accidental (unintentional), sequela |
| T36.3X2A | Poisoning by macrolides, intentional self-harm, initial encounter |
| T36.3X2D | Poisoning by macrolides, intentional self-harm, subsequent encounter |
| T36.3X2S | Poisoning by macrolides, intentional self-harm, sequela |
| T36.3X3A | Poisoning by macrolides, assault, initial encounter |
| T36.3X3D | Poisoning by macrolides, assault, subsequent encounter |
| T36.3X3S | Poisoning by macrolides, assault, sequela |
| T36.3X4A | Poisoning by macrolides, undetermined, initial encounter |
| T36.3X4D | Poisoning by macrolides, undetermined, subsequent encounter |
| T36.3X4S | Poisoning by macrolides, undetermined, sequela |
| T36.3X5A | Adverse effect of macrolides, initial encounter |
| T36.3X5D | Adverse effect of macrolides, subsequent encounter |
| T36.3X5S | Adverse effect of macrolides, sequela |
| T36.3X6A | Underdosing of macrolides, initial encounter |
| T36.3X6D | Underdosing of macrolides, subsequent encounter |
| T36.3X6S | Underdosing of macrolides, sequela |
| T36.4X1A | Poisoning by tetracyclines, accidental (unintentional), initial encounter |
| T36.4X1D | Poisoning by tetracyclines, accidental (unintentional), subsequent encounter |
| T36.4X1S | Poisoning by tetracyclines, accidental (unintentional), sequela |
| T36.4X2A | Poisoning by tetracyclines, intentional self-harm, initial encounter |
| T36.4X2D | Poisoning by tetracyclines, intentional self-harm, subsequent encounter |
| T36.4X2S | Poisoning by tetracyclines, intentional self-harm, sequela |
| T36.4X3A | Poisoning by tetracyclines, assault, initial encounter |
| T36.4X3D | Poisoning by tetracyclines, assault, subsequent encounter |
| T36.4X3S | Poisoning by tetracyclines, assault, sequela |
| T36.4X4A | Poisoning by tetracyclines, undetermined, initial encounter |
| T36.4X4D | Poisoning by tetracyclines, undetermined, subsequent encounter |
| T36.4X4S | Poisoning by tetracyclines, undetermined, sequela |
| T36.4X5A | Adverse effect of tetracyclines, initial encounter |
| T36.4X5D | Adverse effect of tetracyclines, subsequent encounter |
| T36.4X5S | Adverse effect of tetracyclines, sequela |
| T36.4X6A | Underdosing of tetracyclines, initial encounter |
| T36.4X6D | Underdosing of tetracyclines, subsequent encounter |
| T36.4X6S | Underdosing of tetracyclines, sequela |
| T36.5X1A | Poisoning by aminoglycosides, accidental (unintentional), initial encounter |
| T36.5X1D | Poisoning by aminoglycosides, accidental (unintentional), subsequent encounter |
| T36.5X1S | Poisoning by aminoglycosides, accidental (unintentional), sequela |
| T36.5X2A | Poisoning by aminoglycosides, intentional self-harm, initial encounter |
| T36.5X2D | Poisoning by aminoglycosides, intentional self-harm, subsequent encounter |
| T36.5X2S | Poisoning by aminoglycosides, intentional self-harm, sequela |
| T36.5X3A | Poisoning by aminoglycosides, assault, initial encounter |
| T36.5X3D | Poisoning by aminoglycosides, assault, subsequent encounter |
| T36.5X3S | Poisoning by aminoglycosides, assault, sequela |
| T36.5X4A | Poisoning by aminoglycosides, undetermined, initial encounter |
| T36.5X4D | Poisoning by aminoglycosides, undetermined, subsequent encounter |
| T36.5X4S | Poisoning by aminoglycosides, undetermined, sequela |
| T36.5X5A | Adverse effect of aminoglycosides, initial encounter |
| T36.5X5D | Adverse effect of aminoglycosides, subsequent encounter |
| T36.5X5S | Adverse effect of aminoglycosides, sequela |
| T36.5X6A | Underdosing of aminoglycosides, initial encounter |
| T36.5X6D | Underdosing of aminoglycosides, subsequent encounter |
| T36.5X6S | Underdosing of aminoglycosides, sequela |
| T36.6X1A | Poisoning by rifampicins, accidental (unintentional), initial encounter |
| T36.6X1D | Poisoning by rifampicins, accidental (unintentional), subsequent encounter |
| T36.6X1S | Poisoning by rifampicins, accidental (unintentional), sequela |
| T36.6X2A | Poisoning by rifampicins, intentional self-harm, initial encounter |
| T36.6X2D | Poisoning by rifampicins, intentional self-harm, subsequent encounter |
| T36.6X2S | Poisoning by rifampicins, intentional self-harm, sequela |
| T36.6X3A | Poisoning by rifampicins, assault, initial encounter |
| T36.6X3D | Poisoning by rifampicins, assault, subsequent encounter |
| T36.6X3S | Poisoning by rifampicins, assault, sequela |
| T36.6X4A | Poisoning by rifampicins, undetermined, initial encounter |
| T36.6X4D | Poisoning by rifampicins, undetermined, subsequent encounter |
| T36.6X4S | Poisoning by rifampicins, undetermined, sequela |
| T36.6X5A | Adverse effect of rifampicins, initial encounter |
| T36.6X5D | Adverse effect of rifampicins, subsequent encounter |
| T36.6X5S | Adverse effect of rifampicins, sequela |
| T36.6X6A | Underdosing of rifampicins, initial encounter |
| T36.6X6D | Underdosing of rifampicins, subsequent encounter |
| T36.6X6S | Underdosing of rifampicins, sequela |
| T36.7X1A | Poisoning by antifungal antibiotics, systemically used, accidental (unintentional), initial encounter |
| T36.7X1D | Poisoning by antifungal antibiotics, systemically used, accidental (unintentional), subsequent encounter |
| T36.7X1S | Poisoning by antifungal antibiotics, systemically used, accidental (unintentional), sequela |
| T36.7X2A | Poisoning by antifungal antibiotics, systemically used, intentional self-harm, initial encounter |
| T36.7X2D | Poisoning by antifungal antibiotics, systemically used, intentional self-harm, subsequent encounter |
| T36.7X2S | Poisoning by antifungal antibiotics, systemically used, intentional self-harm, sequela |
| T36.7X3A | Poisoning by antifungal antibiotics, systemically used, assault, initial encounter |
| T36.7X3D | Poisoning by antifungal antibiotics, systemically used, assault, subsequent encounter |
| T36.7X3S | Poisoning by antifungal antibiotics, systemically used, assault, sequela |
| T36.7X4A | Poisoning by antifungal antibiotics, systemically used, undetermined, initial encounter |
| T36.7X4D | Poisoning by antifungal antibiotics, systemically used, undetermined, subsequent encounter |
| T36.7X4S | Poisoning by antifungal antibiotics, systemically used, undetermined, sequela |
| T36.7X5A | Adverse effect of antifungal antibiotics, systemically used, initial encounter |
| T36.7X5D | Adverse effect of antifungal antibiotics, systemically used, subsequent encounter |
| T36.7X5S | Adverse effect of antifungal antibiotics, systemically used, sequela |
| T36.7X6A | Underdosing of antifungal antibiotics, systemically used, initial encounter |
| T36.7X6D | Underdosing of antifungal antibiotics, systemically used, subsequent encounter |
| T36.7X6S | Underdosing of antifungal antibiotics, systemically used, sequela |
| T36.8X1A | Poisoning by other systemic antibiotics, accidental (unintentional), initial encounter |
| T36.8X1D | Poisoning by other systemic antibiotics, accidental (unintentional), subsequent encounter |
| T36.8X1S | Poisoning by other systemic antibiotics, accidental (unintentional), sequela |
| T36.8X2A | Poisoning by other systemic antibiotics, intentional self-harm, initial encounter |
| T36.8X2D | Poisoning by other systemic antibiotics, intentional self-harm, subsequent encounter |
Showing the first 400 of 3713 covered codes — this procedure has a large covered-diagnosis set; see the governing LCD/article for the complete list.
Frequently asked questions
Which ICD-10 codes support medical necessity for CPT 95044?
Medicare coverage policies (LCDs/NCDs and Billing & Coding articles) list 3713 ICD-10 diagnosis codes that support medical necessity for CPT 95044. The covered codes are listed on this page. Coverage varies by MAC/state — always confirm against the policy that applies to you.
What is a medical-necessity (LCD/NCD) crosswalk?
A claim whose procedure isn't supported by a covered diagnosis denies as "not medically necessary" (CARC 50). CMS coverage policies define which diagnoses justify a procedure; this page is the ICD-10 → CPT 95044 view of that relationship.
Catch medical-necessity denials before you bill. CareNiva scrubs claims against LCD/NCD coverage and flags unsupported diagnoses — in the same platform you run visits and billing.
More free billing tools: all crosswalks · NCCI edits · Medicare fees · denial codes
Informational only, not coding, billing, or legal advice. Based on CMS Medicare Coverage Database data; verify the current LCD/NCD for your MAC before billing.
Bill it right the first time
Join providers across the country delivering modern virtual care with CareNiva. Free to start, ready in minutes.
100% Satisfaction Guaranteed — try it risk-free